Techtran Polylenses’ will now be incorporating wholly owned Non Banking Finance Company (NBFC). The company’s board of directors in the meeting held on June 08, 2011 approved the same. However, the board in the same meeting also approved the scheme of amalgamation of Hemarus Therapeutics with the company. The share exchange ratio fixed for the amalgamation is 1:14, i.e. for every 1 share of Hemarus Therapeutics, 14 shares of Techtran Polylenses will be allotted.
TPL reckons among the world's leading ophthalmic lens manufacturers. Backed by a world-class facility, a highly trained and motivated workforce, a resourceful R&D and absolutely uncompromising standards, TPL lenses are emphatic statement of quality across the American and European markets. TPL's success is built around its state-of-the-art manufacturing facility at Bonthapally, Medak district, about 40km from Hyderabad in Andhra Pradesh, India. The unit currently produces 5 million lenses annually.
Company Name | CMP |
---|---|
Poly Medicure | 2581.85 |
Hemant Surgical Inds | 136.50 |
Nureca Ltd. | 273.50 |
Prevest Denpro | 540.00 |
Centenial Surgical | 125.00 |
View more.. |